According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...
AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...
Proficio Capital Partners cranked up its position in Vertex Pharmaceuticals by 46.6% during the fourth quarter, grabbing 978 ...